DEXAMETHASONE TABLETS
-
Zydus Lifesciences gets USFDA nod to market generic arthritis drug in US
The company has received final approval from the US Food and Drug Administration (USFDA) to market Dexamethasone tablets (1mg), the drug maker said in a statement.
Advertisement
Advertisement